Results 131 to 140 of about 133,701 (287)

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. [PDF]

, 1993
Peter Carmeliet, J M Stassen, Luc Schoonjans, Beverly Ream, Joost J. van den Oord, M De Mol, Richard C. Mulligan, Désiré Collen   +7 more
openalex   +1 more source

Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation

American Journal of Hematology, EarlyView.
ABSTRACT Postpartum hemorrhage (PPH) remains the leading cause of preventable maternal mortality despite standard interventions. Recent fibrinogen trials failed to improve outcomes, prompting interest in coagulation factor XIII (FXIII). FXIII functions as “molecular cement,” cross‐linking fibrin and stabilizing clots.
Jeremy W. Jacobs, Elizabeth A. Abels, Brian D. Adkins, Garrett S. Booth, Victoria Costa, Sheharyar Raza, Michelle Simon, Jennifer S. Woo, Allison P. Wheeler   +8 more
wiley   +1 more source

Hemostasis via an endoscopic full-thickness suturing device with extended cap length method and red dichromatic imaging for deep colonic diverticular bleeding. [PDF]

Endoscopy
Muramatsu T, Fukuzawa M, Yamanishi F, Arashiyama M, Naruse F, Kaketani T, Itoi T.   +6 more
europepmc   +1 more source

Developmental hemostasis: recommendations for laboratories reporting pediatric samples [PDF]

, 2011
Vera Ignjatović, Gili Kenet, Paul Monagle   +2 more
openalex   +1 more source

Proteomic Analysis of Golden Sputum Reveals Pulmonary Complement Activation During Acute Chest Syndrome in Children With Sickle Cell Disease

American Journal of Hematology, EarlyView.
ABSTRACT Acute chest syndrome (ACS) is one of the most common severe complications of sickle cell disease (SCD). In recent years, a major role of inflammation and innate immunity has been evidenced, but ACS pathophysiology remains incompletely understood, and therapeutic options are limited.
Slimane Allali, Nabiha Sbeih, Rachel Rignault‐Bricard, Johanna Bruce, Morgane Le Gall, Claire Heilbronner, Noemie de Cacqueray, Sofia Angyalosy, Melissa Taylor, Joséphine Brice, Mariane de Montalembert, Martina Bevacqua, Emilie‐Fleur Gautier, Olivier Hermine, Thiago Trovati Maciel   +14 more
wiley   +1 more source

Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH. [PDF]

Clin Appl Thromb Hemost
Min SK, Oh SE, An JY, Kim HK, Kim EJ, Choi MG.   +5 more
europepmc   +1 more source

Hemostasis biomarkers in multiple sclerosis [PDF]

, 2018
Nicole Ziliotto, Francesco Bernardi, Dejan Jakimovski, Marcello Baroni, Giovanna Marchetti, Niels Bergsland, Deepa P. Ramasamy, B. Weinstock‐Guttman, Ferdinand Schweser, Paolo Zamboni, Murali Ramanathan, Robert Zivadinov   +11 more
openalex   +1 more source

Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease

American Journal of Hematology, EarlyView.
ABSTRACT Sickle cell disease (SCD) is a chronic inflammatory state, characterized by increased plasma values of inflammatory and angiogenic proteins. Although red blood cell (RBC) transfusion is known to have immunomodulatory effects in other conditions, its potential effects on the inflammatory state in SCD remain largely unknown.
Lydian A. de Ligt, Sanjay R. Thakoerdin, Maud Zwolsman, Gaby Stegemann, Hanke Matlung, Taco W. Kuijpers, Bart J. Biemond, Karin Fijnvandraat, Robin van Bruggen, Erfan Nur   +9 more
wiley   +1 more source

Rapid hemostasis of wounds: A bibliometric analysis of Web of Science Core Collection from 2004 to 2024. [PDF]

Medicine (Baltimore)
Huang GX, Wang JL, Yang Y, Li XL, Wang M.   +4 more
europepmc   +1 more source

Hemostasis [PDF]

Transfusion Alternatives in Transfusion Medicine, 2004
Volker Kretschmer, Ralf Karger, Jean‐François Hardy, Thomas Lecompte   +3 more
openaire   +1 more source